img

Global Piroxicam API Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Piroxicam API Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Piroxicam API market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Piroxicam API market research.
Key manufacturers engaged in the Piroxicam API industry include SK Chemicals, Pfizer, Nostrum, Mylan, Teva, Viwit Pharmaceutical, Pidi Pharmaceutical, Maoxiang Pharmaceutical and Jumpcan Pharmaceutical, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Piroxicam API were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Piroxicam API market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Piroxicam API market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


SK Chemicals
Pfizer
Nostrum
Mylan
Teva
Viwit Pharmaceutical
Pidi Pharmaceutical
Maoxiang Pharmaceutical
Jumpcan Pharmaceutical
Changjiang Pharmaceutical
XinAn Pharmaceutical
Jiangxi Pharmaceutical
Segment by Type
Purity≥ 99%
Purity≥ 99.5%

Segment by Application


Tablets
Capsule
Injection
Ointment

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Piroxicam API report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Piroxicam API Market Overview
1.1 Product Overview and Scope of Piroxicam API
1.2 Piroxicam API Segment by Type
1.2.1 Global Piroxicam API Market Value Comparison by Type (2024-2034)
1.2.2 Purity≥ 99%
1.2.3 Purity≥ 99.5%
1.3 Piroxicam API Segment by Application
1.3.1 Global Piroxicam API Market Value by Application: (2024-2034)
1.3.2 Tablets
1.3.3 Capsule
1.3.4 Injection
1.3.5 Ointment
1.4 Global Piroxicam API Market Size Estimates and Forecasts
1.4.1 Global Piroxicam API Revenue 2024-2034
1.4.2 Global Piroxicam API Sales 2024-2034
1.4.3 Global Piroxicam API Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Piroxicam API Market Competition by Manufacturers
2.1 Global Piroxicam API Sales Market Share by Manufacturers (2024-2024)
2.2 Global Piroxicam API Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Piroxicam API Average Price by Manufacturers (2024-2024)
2.4 Global Piroxicam API Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Piroxicam API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Piroxicam API, Product Type & Application
2.7 Piroxicam API Market Competitive Situation and Trends
2.7.1 Piroxicam API Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Piroxicam API Players Market Share by Revenue
2.7.3 Global Piroxicam API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Piroxicam API Retrospective Market Scenario by Region
3.1 Global Piroxicam API Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Piroxicam API Global Piroxicam API Sales by Region: 2024-2034
3.2.1 Global Piroxicam API Sales by Region: 2024-2024
3.2.2 Global Piroxicam API Sales by Region: 2024-2034
3.3 Global Piroxicam API Global Piroxicam API Revenue by Region: 2024-2034
3.3.1 Global Piroxicam API Revenue by Region: 2024-2024
3.3.2 Global Piroxicam API Revenue by Region: 2024-2034
3.4 North America Piroxicam API Market Facts & Figures by Country
3.4.1 North America Piroxicam API Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Piroxicam API Sales by Country (2024-2034)
3.4.3 North America Piroxicam API Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Piroxicam API Market Facts & Figures by Country
3.5.1 Europe Piroxicam API Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Piroxicam API Sales by Country (2024-2034)
3.5.3 Europe Piroxicam API Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Piroxicam API Market Facts & Figures by Country
3.6.1 Asia Pacific Piroxicam API Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Piroxicam API Sales by Country (2024-2034)
3.6.3 Asia Pacific Piroxicam API Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Piroxicam API Market Facts & Figures by Country
3.7.1 Latin America Piroxicam API Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Piroxicam API Sales by Country (2024-2034)
3.7.3 Latin America Piroxicam API Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Piroxicam API Market Facts & Figures by Country
3.8.1 Middle East and Africa Piroxicam API Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Piroxicam API Sales by Country (2024-2034)
3.8.3 Middle East and Africa Piroxicam API Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Piroxicam API Sales by Type (2024-2034)
4.1.1 Global Piroxicam API Sales by Type (2024-2024)
4.1.2 Global Piroxicam API Sales by Type (2024-2034)
4.1.3 Global Piroxicam API Sales Market Share by Type (2024-2034)
4.2 Global Piroxicam API Revenue by Type (2024-2034)
4.2.1 Global Piroxicam API Revenue by Type (2024-2024)
4.2.2 Global Piroxicam API Revenue by Type (2024-2034)
4.2.3 Global Piroxicam API Revenue Market Share by Type (2024-2034)
4.3 Global Piroxicam API Price by Type (2024-2034)
5 Segment by Application
5.1 Global Piroxicam API Sales by Application (2024-2034)
5.1.1 Global Piroxicam API Sales by Application (2024-2024)
5.1.2 Global Piroxicam API Sales by Application (2024-2034)
5.1.3 Global Piroxicam API Sales Market Share by Application (2024-2034)
5.2 Global Piroxicam API Revenue by Application (2024-2034)
5.2.1 Global Piroxicam API Revenue by Application (2024-2024)
5.2.2 Global Piroxicam API Revenue by Application (2024-2034)
5.2.3 Global Piroxicam API Revenue Market Share by Application (2024-2034)
5.3 Global Piroxicam API Price by Application (2024-2034)
6 Key Companies Profiled
6.1 SK Chemicals
6.1.1 SK Chemicals Corporation Information
6.1.2 SK Chemicals Description and Business Overview
6.1.3 SK Chemicals Piroxicam API Sales, Revenue and Gross Margin (2024-2024)
6.1.4 SK Chemicals Piroxicam API Product Portfolio
6.1.5 SK Chemicals Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Piroxicam API Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Pfizer Piroxicam API Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Nostrum
6.3.1 Nostrum Corporation Information
6.3.2 Nostrum Description and Business Overview
6.3.3 Nostrum Piroxicam API Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Nostrum Piroxicam API Product Portfolio
6.3.5 Nostrum Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Piroxicam API Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Mylan Piroxicam API Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Teva
6.5.1 Teva Corporation Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Piroxicam API Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Teva Piroxicam API Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Viwit Pharmaceutical
6.6.1 Viwit Pharmaceutical Corporation Information
6.6.2 Viwit Pharmaceutical Description and Business Overview
6.6.3 Viwit Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Viwit Pharmaceutical Piroxicam API Product Portfolio
6.6.5 Viwit Pharmaceutical Recent Developments/Updates
6.7 Pidi Pharmaceutical
6.6.1 Pidi Pharmaceutical Corporation Information
6.6.2 Pidi Pharmaceutical Description and Business Overview
6.6.3 Pidi Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Pidi Pharmaceutical Piroxicam API Product Portfolio
6.7.5 Pidi Pharmaceutical Recent Developments/Updates
6.8 Maoxiang Pharmaceutical
6.8.1 Maoxiang Pharmaceutical Corporation Information
6.8.2 Maoxiang Pharmaceutical Description and Business Overview
6.8.3 Maoxiang Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Maoxiang Pharmaceutical Piroxicam API Product Portfolio
6.8.5 Maoxiang Pharmaceutical Recent Developments/Updates
6.9 Jumpcan Pharmaceutical
6.9.1 Jumpcan Pharmaceutical Corporation Information
6.9.2 Jumpcan Pharmaceutical Description and Business Overview
6.9.3 Jumpcan Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Jumpcan Pharmaceutical Piroxicam API Product Portfolio
6.9.5 Jumpcan Pharmaceutical Recent Developments/Updates
6.10 Changjiang Pharmaceutical
6.10.1 Changjiang Pharmaceutical Corporation Information
6.10.2 Changjiang Pharmaceutical Description and Business Overview
6.10.3 Changjiang Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Changjiang Pharmaceutical Piroxicam API Product Portfolio
6.10.5 Changjiang Pharmaceutical Recent Developments/Updates
6.11 XinAn Pharmaceutical
6.11.1 XinAn Pharmaceutical Corporation Information
6.11.2 XinAn Pharmaceutical Piroxicam API Description and Business Overview
6.11.3 XinAn Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2024-2024)
6.11.4 XinAn Pharmaceutical Piroxicam API Product Portfolio
6.11.5 XinAn Pharmaceutical Recent Developments/Updates
6.12 Jiangxi Pharmaceutical
6.12.1 Jiangxi Pharmaceutical Corporation Information
6.12.2 Jiangxi Pharmaceutical Piroxicam API Description and Business Overview
6.12.3 Jiangxi Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2024-2024)
6.12.4 Jiangxi Pharmaceutical Piroxicam API Product Portfolio
6.12.5 Jiangxi Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Piroxicam API Industry Chain Analysis
7.2 Piroxicam API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Piroxicam API Production Mode & Process
7.4 Piroxicam API Sales and Marketing
7.4.1 Piroxicam API Sales Channels
7.4.2 Piroxicam API Distributors
7.5 Piroxicam API Customers
8 Piroxicam API Market Dynamics
8.1 Piroxicam API Industry Trends
8.2 Piroxicam API Market Drivers
8.3 Piroxicam API Market Challenges
8.4 Piroxicam API Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Piroxicam API Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Piroxicam API Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Piroxicam API Market Competitive Situation by Manufacturers in 2022
Table 4. Global Piroxicam API Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Piroxicam API Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Piroxicam API Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Piroxicam API Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Piroxicam API Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Piroxicam API, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Piroxicam API, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Piroxicam API, Product Type & Application
Table 12. Global Key Manufacturers of Piroxicam API, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Piroxicam API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Piroxicam API as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Piroxicam API Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Piroxicam API Sales by Region (2024-2024) & (K Units)
Table 18. Global Piroxicam API Sales Market Share by Region (2024-2024)
Table 19. Global Piroxicam API Sales by Region (2024-2034) & (K Units)
Table 20. Global Piroxicam API Sales Market Share by Region (2024-2034)
Table 21. Global Piroxicam API Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Piroxicam API Revenue Market Share by Region (2024-2024)
Table 23. Global Piroxicam API Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Piroxicam API Revenue Market Share by Region (2024-2034)
Table 25. North America Piroxicam API Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Piroxicam API Sales by Country (2024-2024) & (K Units)
Table 27. North America Piroxicam API Sales by Country (2024-2034) & (K Units)
Table 28. North America Piroxicam API Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Piroxicam API Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Piroxicam API Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Piroxicam API Sales by Country (2024-2024) & (K Units)
Table 32. Europe Piroxicam API Sales by Country (2024-2034) & (K Units)
Table 33. Europe Piroxicam API Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Piroxicam API Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Piroxicam API Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Piroxicam API Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Piroxicam API Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Piroxicam API Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Piroxicam API Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Piroxicam API Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Piroxicam API Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Piroxicam API Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Piroxicam API Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Piroxicam API Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Piroxicam API Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Piroxicam API Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Piroxicam API Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Piroxicam API Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Piroxicam API Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Piroxicam API Sales (K Units) by Type (2024-2024)
Table 51. Global Piroxicam API Sales (K Units) by Type (2024-2034)
Table 52. Global Piroxicam API Sales Market Share by Type (2024-2024)
Table 53. Global Piroxicam API Sales Market Share by Type (2024-2034)
Table 54. Global Piroxicam API Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Piroxicam API Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Piroxicam API Revenue Market Share by Type (2024-2024)
Table 57. Global Piroxicam API Revenue Market Share by Type (2024-2034)
Table 58. Global Piroxicam API Price (US$/Unit) by Type (2024-2024)
Table 59. Global Piroxicam API Price (US$/Unit) by Type (2024-2034)
Table 60. Global Piroxicam API Sales (K Units) by Application (2024-2024)
Table 61. Global Piroxicam API Sales (K Units) by Application (2024-2034)
Table 62. Global Piroxicam API Sales Market Share by Application (2024-2024)
Table 63. Global Piroxicam API Sales Market Share by Application (2024-2034)
Table 64. Global Piroxicam API Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Piroxicam API Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Piroxicam API Revenue Market Share by Application (2024-2024)
Table 67. Global Piroxicam API Revenue Market Share by Application (2024-2034)
Table 68. Global Piroxicam API Price (US$/Unit) by Application (2024-2024)
Table 69. Global Piroxicam API Price (US$/Unit) by Application (2024-2034)
Table 70. SK Chemicals Corporation Information
Table 71. SK Chemicals Description and Business Overview
Table 72. SK Chemicals Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. SK Chemicals Piroxicam API Product
Table 74. SK Chemicals Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Pfizer Piroxicam API Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Nostrum Corporation Information
Table 81. Nostrum Description and Business Overview
Table 82. Nostrum Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Nostrum Piroxicam API Product
Table 84. Nostrum Recent Developments/Updates
Table 85. Mylan Corporation Information
Table 86. Mylan Description and Business Overview
Table 87. Mylan Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. Mylan Piroxicam API Product
Table 89. Mylan Recent Developments/Updates
Table 90. Teva Corporation Information
Table 91. Teva Description and Business Overview
Table 92. Teva Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Teva Piroxicam API Product
Table 94. Teva Recent Developments/Updates
Table 95. Viwit Pharmaceutical Corporation Information
Table 96. Viwit Pharmaceutical Description and Business Overview
Table 97. Viwit Pharmaceutical Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Viwit Pharmaceutical Piroxicam API Product
Table 99. Viwit Pharmaceutical Recent Developments/Updates
Table 100. Pidi Pharmaceutical Corporation Information
Table 101. Pidi Pharmaceutical Description and Business Overview
Table 102. Pidi Pharmaceutical Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. Pidi Pharmaceutical Piroxicam API Product
Table 104. Pidi Pharmaceutical Recent Developments/Updates
Table 105. Maoxiang Pharmaceutical Corporation Information
Table 106. Maoxiang Pharmaceutical Description and Business Overview
Table 107. Maoxiang Pharmaceutical Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. Maoxiang Pharmaceutical Piroxicam API Product
Table 109. Maoxiang Pharmaceutical Recent Developments/Updates
Table 110. Jumpcan Pharmaceutical Corporation Information
Table 111. Jumpcan Pharmaceutical Description and Business Overview
Table 112. Jumpcan Pharmaceutical Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Jumpcan Pharmaceutical Piroxicam API Product
Table 114. Jumpcan Pharmaceutical Recent Developments/Updates
Table 115. Changjiang Pharmaceutical Corporation Information
Table 116. Changjiang Pharmaceutical Description and Business Overview
Table 117. Changjiang Pharmaceutical Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Changjiang Pharmaceutical Piroxicam API Product
Table 119. Changjiang Pharmaceutical Recent Developments/Updates
Table 120. XinAn Pharmaceutical Corporation Information
Table 121. XinAn Pharmaceutical Description and Business Overview
Table 122. XinAn Pharmaceutical Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. XinAn Pharmaceutical Piroxicam API Product
Table 124. XinAn Pharmaceutical Recent Developments/Updates
Table 125. Jiangxi Pharmaceutical Corporation Information
Table 126. Jiangxi Pharmaceutical Description and Business Overview
Table 127. Jiangxi Pharmaceutical Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. Jiangxi Pharmaceutical Piroxicam API Product
Table 129. Jiangxi Pharmaceutical Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Piroxicam API Distributors List
Table 133. Piroxicam API Customers List
Table 134. Piroxicam API Market Trends
Table 135. Piroxicam API Market Drivers
Table 136. Piroxicam API Market Challenges
Table 137. Piroxicam API Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Piroxicam API
Figure 2. Global Piroxicam API Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Piroxicam API Market Share by Type in 2022 & 2034
Figure 4. Purity≥ 99% Product Picture
Figure 5. Purity≥ 99.5% Product Picture
Figure 6. Global Piroxicam API Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Piroxicam API Market Share by Application in 2022 & 2034
Figure 8. Tablets
Figure 9. Capsule
Figure 10. Injection
Figure 11. Ointment
Figure 12. Global Piroxicam API Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 13. Global Piroxicam API Market Size (2024-2034) & (US$ Million)
Figure 14. Global Piroxicam API Sales (2024-2034) & (K Units)
Figure 15. Global Piroxicam API Average Price (US$/Unit) & (2024-2034)
Figure 16. Piroxicam API Report Years Considered
Figure 17. Piroxicam API Sales Share by Manufacturers in 2022
Figure 18. Global Piroxicam API Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Piroxicam API Players: Market Share by Revenue in 2022
Figure 20. Piroxicam API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 21. Global Piroxicam API Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 22. North America Piroxicam API Sales Market Share by Country (2024-2034)
Figure 23. North America Piroxicam API Revenue Market Share by Country (2024-2034)
Figure 24. United States Piroxicam API Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 25. Canada Piroxicam API Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 26. Europe Piroxicam API Sales Market Share by Country (2024-2034)
Figure 27. Europe Piroxicam API Revenue Market Share by Country (2024-2034)
Figure 28. Germany Piroxicam API Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. France Piroxicam API Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. U.K. Piroxicam API Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. Italy Piroxicam API Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. Russia Piroxicam API Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. Asia Pacific Piroxicam API Sales Market Share by Region (2024-2034)
Figure 34. Asia Pacific Piroxicam API Revenue Market Share by Region (2024-2034)
Figure 35. China Piroxicam API Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. Japan Piroxicam API Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. South Korea Piroxicam API Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. India Piroxicam API Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. Australia Piroxicam API Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. China Taiwan Piroxicam API Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Southeast Asia Piroxicam API Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. Latin America Piroxicam API Sales Market Share by Country (2024-2034)
Figure 43. Latin America Piroxicam API Revenue Market Share by Country (2024-2034)
Figure 44. Mexico Piroxicam API Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Brazil Piroxicam API Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 46. Argentina Piroxicam API Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 47. Middle East & Africa Piroxicam API Sales Market Share by Country (2024-2034)
Figure 48. Middle East & Africa Piroxicam API Revenue Market Share by Country (2024-2034)
Figure 49. Turkey Piroxicam API Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Saudi Arabia Piroxicam API Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 51. UAE Piroxicam API Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 52. Global Sales Market Share of Piroxicam API by Type (2024-2034)
Figure 53. Global Revenue Market Share of Piroxicam API by Type (2024-2034)
Figure 54. Global Piroxicam API Price (US$/Unit) by Type (2024-2034)
Figure 55. Global Sales Market Share of Piroxicam API by Application (2024-2034)
Figure 56. Global Revenue Market Share of Piroxicam API by Application (2024-2034)
Figure 57. Global Piroxicam API Price (US$/Unit) by Application (2024-2034)
Figure 58. Piroxicam API Value Chain
Figure 59. Piroxicam API Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed